A Randomized, Double-Blind, Placebo Controlled, Parallel-Group, Multicenter, Phase II Study to Evaluate the Efficacy and Safety of MABT5102A in Patients With Mild to Moderate Alzheimer's Disease (ABBY)
收藏DataCite Commons2025-05-01 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/PR00010088/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
This is a Phase II, randomized, double-blind, parallel-group, placebo-controlled study to
evaluate the safety and efficacy of MABT5102A in patients with mild to moderate Alzheimer's
Disease.
提供机构：
Vivli
创建时间：
2024-05-01
